Correlation Between Armata Pharmaceuticals and OS Therapies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Armata Pharmaceuticals and OS Therapies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armata Pharmaceuticals and OS Therapies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Armata Pharmaceuticals and OS Therapies Incorporated, you can compare the effects of market volatilities on Armata Pharmaceuticals and OS Therapies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armata Pharmaceuticals with a short position of OS Therapies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armata Pharmaceuticals and OS Therapies.

Diversification Opportunities for Armata Pharmaceuticals and OS Therapies

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Armata and OSTX is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Armata Pharmaceuticals and OS Therapies Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OS Therapies and Armata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armata Pharmaceuticals are associated (or correlated) with OS Therapies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OS Therapies has no effect on the direction of Armata Pharmaceuticals i.e., Armata Pharmaceuticals and OS Therapies go up and down completely randomly.

Pair Corralation between Armata Pharmaceuticals and OS Therapies

Given the investment horizon of 90 days Armata Pharmaceuticals is expected to generate 0.41 times more return on investment than OS Therapies. However, Armata Pharmaceuticals is 2.44 times less risky than OS Therapies. It trades about 0.12 of its potential returns per unit of risk. OS Therapies Incorporated is currently generating about -0.3 per unit of risk. If you would invest  190.00  in Armata Pharmaceuticals on October 31, 2024 and sell it today you would earn a total of  14.00  from holding Armata Pharmaceuticals or generate 7.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Armata Pharmaceuticals  vs.  OS Therapies Incorporated

 Performance 
       Timeline  
Armata Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Armata Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Armata Pharmaceuticals is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
OS Therapies 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in OS Therapies Incorporated are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, OS Therapies showed solid returns over the last few months and may actually be approaching a breakup point.

Armata Pharmaceuticals and OS Therapies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Armata Pharmaceuticals and OS Therapies

The main advantage of trading using opposite Armata Pharmaceuticals and OS Therapies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armata Pharmaceuticals position performs unexpectedly, OS Therapies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OS Therapies will offset losses from the drop in OS Therapies' long position.
The idea behind Armata Pharmaceuticals and OS Therapies Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA